Medicare Enrolled

Dr. Manuel Bloom, M.D

Pulmonary Disease · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
6550 FANNIN ST STE 1101, Houston, TX 77030
7134413948
In practice since 2006 (19 years)
NPI: 1023029089 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bloom from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bloom? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bloom

Dr. Manuel Bloom is a pulmonary disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Bloom performed 1,309 Medicare services across 490 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bloom received a total of $23,643 from 50 pharmaceutical and/or device companies across 1160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bloom is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 38% volume in TX$ $23,643 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,309
Medicare services
Top 38% in TX for pulmonary disease
490
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~69 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, moderate complexity691$63$176
Office visit, established patient (30-39 min)397$93$273
Hospital follow-up visit, high complexity56$94$254
New patient office visit (45-59 min)50$125$432
Initial hospital admission, moderate complexity46$104$401
Initial hospital admission, high complexity37$137$300
Test to measure expiratory airflow and volume32$20$80
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,643
Total received (2018-2024)
Avg $3,378/year across 7 years
Top 10% in TX for pulmonary disease
50
Companies
1,160
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,576 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$48 (0.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$19 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,428
2023
$2,941
2022
$4,419
2021
$2,972
2020
$2,805
2019
$4,262
2018
$3,816

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$3,673
AstraZeneca Pharmaceuticals LP
$3,378
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,800
Actelion Pharmaceuticals US, Inc.
$2,635
GENZYME CORPORATION
$992
United Therapeutics Corporation
$905
Regeneron Healthcare Solutions, Inc.
$861
Mylan Specialty L.P.
$818
Sunovion Pharmaceuticals Inc.
$791
Mallinckrodt Hospital Products Inc.
$659
Shionogi Inc
$637
Baxter Healthcare
$621
Insmed, Inc.
$517
Takeda Pharmaceuticals U.S.A., Inc.
$507
Advanced Respiratory, Inc
$364
Grifols USA, LLC
$360
Bayer HealthCare Pharmaceuticals Inc.
$330
PFIZER INC.
$307
Mallinckrodt LLC
$274
Merck Sharp & Dohme Corporation
$246
Shire North American Group Inc
$195
Genentech USA, Inc.
$148
Gilead Sciences, Inc.
$146
JAZZ PHARMACEUTICALS INC.
$140
Bayer Healthcare Pharmaceuticals Inc.
$104
Teva Pharmaceuticals USA, Inc.
$88
ABBVIE INC.
$85
Electromed, Inc.
$82
Mallinckrodt Enterprises LLC
$80
Exeltis, USA Inc.
$77
ANI Pharmaceuticals, Inc.
$74
PORTOLA PHARMACEUTICALS, INC.
$72
Resmed Corp
$62
Amgen Inc.
$57
AbbVie Inc.
$57
INOGEN, INC.
$55
Merck Sharp & Dohme LLC
$52
Pharming Healthcare, Inc.
$51
Genentech, Inc.
$48
Circassia Pharmaceuticals Inc
$47
E.R. Squibb & Sons, L.L.C.
$47
Paratek Pharmaceuticals, Inc.
$45
ADVANCED RESPIRATORY, INC
$28
Johnson & Johnson Health Care Systems Inc.
$27
Medtronic Vascular, Inc.
$20
Itamar Medical Inc
$19
Inogen, Inc.
$18
Alexion Pharmaceuticals, Inc.
$17
Philips Electronics North America Corporation
$15
Acerta Pharma LLC
$13
Top 3 companies account for 41.7% of total payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · ASMANEX · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CINQAIR · CUVITRU · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · Esbriet · FARXIGA · FASENRA · Fetroja · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · KEYTRUDA · LONHALA MAGNAIR · Letairis · NIOX VERO · NUCALA · NUZYRA · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PANZYGA · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · RUCONEST · Reveal LINQ · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · ULTOMIRIS · UPTRAVI · Utibron · WINREVAIR · WatchPAT · Wellcentive Undiv · XYWAV · Xembify · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for pulmonary disease in TX.

Equivalent to $1,806 per 100 Medicare services performed
Looking for a pulmonary disease in Houston?
Compare pulmonary diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
136
Per 100K population
2.9
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bloom is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 10%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bloom experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Bloom performed 691 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bloom receive payments from pharmaceutical companies?
Yes. Dr. Bloom received a total of $23,643 from 50 companies across 1,160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bloom's costs compare to other pulmonary diseases in Houston?
Dr. Bloom's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bloom) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →